Skip to main content
SpringerLink
Log in

Primary liver cancer

Quadrennial review lecture

  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

Liver cancer, whether primary or secondary, is one of the most difficult to treat among malignant solid tumors, with a miserable prognosis. In view of the relative lack of exciting progress in the management of metastatic liver cancer in recent years this lecture necessarily concerns primary liver cancer, particularly hepatocellular carcinoma (HCC). Time permits coverage of only several important aspects of general interest and recent advances in the study of HCC.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Tong MJ, Sun SC, Schaeffe BT, et al: Hepatitis-associated antigen and hepatocellular carcinoma in Taiwan. Ann Intern Med 75:687–691, 1971

    CAS  PubMed  Google Scholar 

  2. Beasley RP, Hwang LY, Lin CC, Chien CS: Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22,707 men in Taiwan. Lancet 2:1129–1133, 1981

    Article  CAS  PubMed  Google Scholar 

  3. Beasley RP: Hepatitis B virus as the etiologic agent in hepatocellular carcinoma—epidemiologic considerations. Hepatology 2:21S-26S, 1982

    Google Scholar 

  4. Bréchot C, Pourcel C, Louise A, et al: Presence of integrated hepatitis B virus DNA in cellular DNA of human hepatocellular carcinoma. Nature 286:533–535, 1980

    Article  PubMed  Google Scholar 

  5. Bréchot C, Hadchouel M, Scott J, et al: State of hepatitis B virus DNA in hepatocytes of patients with HBsAg-positive and HBsAg-negative liver disease. Proc Natl Acad Sci USA 78:3306–3310, 1981

    Article  Google Scholar 

  6. Shafritz DA: Hepatitis B virus DNA molecules in the liver of HBsAg carriers: Mechanistic consideration in the pathogenesis of hepatocellular carcinoma. Hepatology 2:35S-41S, 1982

    Google Scholar 

  7. Popper H, Gerber MA, Thung SN: The relation of hepatocellular carcinoma to infection with hepatitis B and related viruses in man and animals. Hepatology 2:1S-9S, 1982

    Google Scholar 

  8. Bréchot C, Degos F, Lugassy C, et al: Hepatitis B virus DNA in patients with chronic liver disease and negative tests for hepatitis B surface antigen. N Engl J Med 312:270–276, 1985

    Article  PubMed  Google Scholar 

  9. Summers J, Smoles JM, Snyder R: A virus similar to hepatitis B virus associated with hepatitis and hepatoma in woodchucks. Proc Natl Acad Sci USA 75:4533–4537, 1978

    Article  CAS  PubMed  Google Scholar 

  10. Popper H, Shih JWK, Gerin JL, et al: Woodchuck hepatitis and hepatocellular carcinoma: Correlation of histologic with virologic observations. Hepatology 1:91–98, 1981

    Article  CAS  PubMed  Google Scholar 

  11. Omata M, Uchiumi K Ito Y, et al: Duck hepatitis B virus and liver diseases. Gastroenterology 85:260–267 1983

    CAS  PubMed  Google Scholar 

  12. Yokosuka O, Omata M, Zhou YZ, Imazeki F, Okuda K: Duck hepatitis B virus in liver and serum of Chinese ducks: Integration of viral DNA in a hepatocellular carcinoma. Proc Natl Acad Sci USA 82:5180–5184, 1985

    Article  CAS  PubMed  Google Scholar 

  13. Omata M, Yokosuka O, Imazeki F, et al: Transmission of duck hepatitis B virus from Chinese carrier ducks to Japanese ducklings: A study of viral DNA in serum and tissue. Hepatology 4:603–607, 1984

    Article  CAS  PubMed  Google Scholar 

  14. Sakuma K, Takahara T, Okuda K, Tsuda F, Mayumi M: Prognosis of hepatitis B virus surface antigen carriers in relation to routine liver function tests: A prospective study. Gastroenterology 83:114–117, 1982

    CAS  PubMed  Google Scholar 

  15. Okuda K, Mackay I: Hepatocellular carcinoma. UICC Tech Rep Ser 74:67–76, 1982

    Google Scholar 

  16. Okuda K Kubo Y, Okazaki N, et al: Clinical aspects of intrahepatic bile duct carcinoma including hilar carcinoma A study of 57 autopsy-proven cases. Cancer 39:232–246, 1977

    Article  CAS  PubMed  Google Scholar 

  17. Saracci R, Repetto F: Time trends of primary liver cancer: Indication of increased incidence in selected cancer registry populations. J Natl Cancer Inst 65:241–247, 1980

    CAS  PubMed  Google Scholar 

  18. Lee FI: Cirrhosis and hepatoma in alcoholics. Gut 7:77–95, 1966

    Article  CAS  PubMed  Google Scholar 

  19. Okuda K, Musha H, Nakajima Y, et al: Clinicopathological features of encapsulated hepatocellular carcinoma. A study of 26 cases. Cancer 40:1240–1245, 1977

    Article  CAS  PubMed  Google Scholar 

  20. Okuda K, Peters RL, Simson IW: Gross anatomical features of hepatocellular carcinoma from three disparate geographic areas. Proposal of new classification. Cancer 54:2165–2173, 1984

    Article  CAS  PubMed  Google Scholar 

  21. Shikata T: Primary liver carcinoma and liver cirrhosis.In Hepatocellular Carcinoma. K Okuda, RL Peters, (eds). New York, Wiley, 1976, pp 53–72

    Google Scholar 

  22. Peters RL: Pathology of hepatocellular carcinoma.In Hepatocellular Carcinoma. K Okuda, RL Peters (eds). New York Wiley, 1976, pp 107–168

    Google Scholar 

  23. Primack A, Vogel CL, Kyalwazi SK, et al: A staging system for hepatocellular carcinoma: Prognostic factors in Ugandan patients. Cancer 35:1257–1264, 1975

    Article  Google Scholar 

  24. Okuda K, Ohtsuki T, Obata H, et al: Natural history of hepatocellular carcinoma and prognosis in relation to treatment. Study of 850 patients. Cancer 56:918–928, 1985

    Article  CAS  PubMed  Google Scholar 

  25. Peers RG, Linsell CA: Dietary aflatoxin and liver cancer; a population based study in Kenya. Br J Cancer 27:473–484, 1973

    CAS  PubMed  Google Scholar 

  26. Wogan GN: Dietary factors and special epidemological situations of liver cancer in Thailand and Africa. Cancer Res 35:3499–3502, 1975

    CAS  PubMed  Google Scholar 

  27. Steiner PE: Cancer of the liver and cirrhosis in trans-Saharan Africa and the United States of America. Cancer 13:1085–1166, 1960

    Article  Google Scholar 

  28. Anthony PP, Vogel CL, Barker LF: Liver cell dysplasia: A premalignant condition. J Clin Pathol 26:217–223, 1973

    Article  CAS  PubMed  Google Scholar 

  29. Anthony PP: Precusor lesions for liver cancer in humans. Cancer Res 36:2579–2583, 1976

    CAS  PubMed  Google Scholar 

  30. Omata M, Mori J, Yokosuka O, et al: Hepatitis B virus antigens in liver tissue in hepatocellular carcinoma and advanced chronic liver disease—relationship to liver cell dysplasia. Liver 2:125–132, 1982

    CAS  PubMed  Google Scholar 

  31. Uchida T, Mayama H, Shikata T: Human hepatocellular carcinoma and putative precacerous disorders. Arch Pathol Lab Med 105:180–186, 1981

    CAS  PubMed  Google Scholar 

  32. Chen DS, Sheu JC, Sung JL, et al: Small hepatocellular carcinoma—a clinicopathological study in thirteen patients. Gastroenterology 83:1109–1119, 1983

    Google Scholar 

  33. Shinagawa T, Ohto M, Kimura K, et al: Diagnosis and clinical features of small hepatocellular carcinoma with emphasis on the utility of real-time ultrasonography. A study in 51 patients. Gastroenterology 86:495–502, 1984

    CAS  PubMed  Google Scholar 

  34. Ebara M, Ohto M, Shinagawa T, et al: Natural history of minute hepatocellular carcinoma smaller than three centimeters complicating cirrhosis. A study in 22 patients. Gastroenterology 90:289–298, 1986

    CAS  PubMed  Google Scholar 

  35. Arakawa M, Sugihara S, Kenmochi K, et al: Small mass lesions in cirrhosis. Transition from benign adenomatous hyperplasia to hepatocellular carcinoma? J Gastroenterol Hepatol 1:3–14, 1986

    Article  Google Scholar 

  36. Edmondson HA: Benign epithelial tumors and tumorlike lesions of the liver.In Hepatocellular Carcinoma. K Okuda, RL Peters (eds). New York, Wiley, 1976, pp 309–332

    Google Scholar 

  37. Obata H, Hayashi N, Motoike Y, et al: A prospective study on the development of hepatocellular carcinoma from liver cirrhosis with persistent hepatitis B virus infection. Int J Cancer 25:741–747, 1980

    Article  CAS  PubMed  Google Scholar 

  38. Chen DS, Sung JL, Sheu JC, et al: Serum α-fetoprotein in the early stage of human hepatocellular carcinoma. Gastroenterology 86:1404–1409, 1984

    CAS  PubMed  Google Scholar 

  39. Ohto M, Karasawa E, Tsuchiya Y, et al: Ultrasonically guided percutaneous contrast medium injection and aspiration biopsy using a real-time puncture transducer. Radiology 136:171–176, 1980

    CAS  PubMed  Google Scholar 

  40. Makuuchi M, Bandai Y, Ito T, et al: Ultrasonically guided percutaneous transhepatic bile drainage. A single-step procedure without cholangiography. Radiology 136:165–169, 1980

    CAS  PubMed  Google Scholar 

  41. Shinagawa T, Ohto M, Kimura K, et al: Real-time ultrasonographic diagnosis of hepatocellular carcinoma. Jpn J Gastroenterol 78:2402–2411, 1981

    CAS  Google Scholar 

  42. Sheu JC, Sung JL, Chen DS, et al: Growth rate of asymptomatic hepatocellular carcinoma and its clinical implications. Gastroenterology 89:259–266, 1985

    CAS  PubMed  Google Scholar 

  43. Yumoto Y, Jinno K, Tokuyama K, et al: Hepatocellular carcinoma detected by iodized oil. Radiology 154:19–24, 1985

    CAS  PubMed  Google Scholar 

  44. Maki S, Konno T, Maeda H: Image enhancement in computed tomography for sensitive diagnosis of liver cancer and semiquantitation of tumors selective drug targeting with oily contrast medium. Cancer 56:751–757, 1985

    Article  CAS  PubMed  Google Scholar 

  45. Lin TY: Surgical treatments of primary liver cell carcinoma.In Hepatocellular Carcinoma. K Okuda, RL Peters (eds). New York, Wiley, 1976, pp 449–468

    Google Scholar 

  46. Okuda K, Liver Cancer Study Group of Japan: Primary liver cancers in Japan. Cancer 45:2663–2669 1980

    Article  Google Scholar 

  47. Zhou XD, Tang ZY: Factors influencing resectability and resection survival rates of subclinical hepatocellular carcinoma.In Subclinical Hepatocellular Carcinoma. ZY Tang (ed). Beijin, China Academy Publishers, 1985, pp 78–84

    Google Scholar 

  48. Liver Cancer Study Group of Japan: Primary liver cancer in Japan. Cancer 54:1747–1755, 1984

    Article  Google Scholar 

  49. Okazaki N: Systemic chemotherapy of hepatocellular carcinoma.In Hepatocellulars Carcinoma, K Okuda, RL Peters (eds). New York, Wiley, 1976, pp 469–476

    Google Scholar 

  50. Kubo Y, Shimokawa Y: Arterial injection chemotherapy.In Hepatocellular Carcinoma. K Okuda, RL Peters (eds). New York, Wiley, 1976, pp 477–490

    Google Scholar 

  51. Yamada R, Sato M, Kawabata M, et al: Hepatic artery embolization in 120 patients with unresectable hepatoma. Radiology 148:397–401, 1983

    CAS  PubMed  Google Scholar 

  52. Takayasu K, Moriyama N, Muramatsu Y, et al: Hepatic arterial embolization for hepatocellular carcinoma. Comparison of CT scans and resected specimens. Radiology 150:661–665, 1984

    CAS  PubMed  Google Scholar 

  53. Furui S, Otomo K, Itai Y, Iio M: Hepatocellular carcinoma treated by transcatheter arterial embolization: Progress evaluation by computed tomography. Radiology 1950:773–778, 1984

    Google Scholar 

  54. Takayasu K, Moriyama N, Muramatsu Y, et al: Gallbladder infarction after hepatic artery embolization. Am J Roentgenol 144:135–138, 1985

    CAS  Google Scholar 

  55. Takyasu K, Moriyama N, Muramatsu Y, et al: Splenic infarction, a complication of transcatheter hepatic arterial embolization for liver malignancies. Radiology 151:371–375, 1984

    Google Scholar 

  56. Okuda K, Musha H, Yoshida T, et al: Demonstration of growing casts of hepatocellular carcinoma in the portal vein by celiac angiography: The thread and streaks sign. Radiology 117:303–309, 1975

    CAS  PubMed  Google Scholar 

  57. Okuda K: Advances in hepatobiliary ultrasonography. Hepatology 1:662–672, 1981

    Article  CAS  PubMed  Google Scholar 

  58. Nakayama T, Hiyama Y, Ohnishi K, et al: Arterial shunts on dynamic computed tomography Am J Roentgenol 140:953–957, 1982

    Google Scholar 

  59. Mathieu D, Grenier P, Larde D, Vasile N: Portal vein involvement in hepatocellular carcinoma: dynamic CT features. Radiology 152:127–132, 1984

    CAS  PubMed  Google Scholar 

  60. Ohnishi K, Okuda K, Ohtsuki T, et al: Formation of hilar collaterals or cavernous tranformation after portal vein obstruction by hepatocellular carcinoma. Observations in ten patients. Gastroenterology 87:1150–1153, 1984

    CAS  PubMed  Google Scholar 

  61. Kato T, Nemoto R, Mori H, et al: Arterial chemoembolization with microencapsulated anticancer drug. An approach to selective cancer chemotherapy with sustained effects. JAMA 245:1123–1127, 1981

    Article  CAS  PubMed  Google Scholar 

  62. Konno T, Maeda H, Iwai K, et al: Effect of arterial administration of high-molecular-weight anticancer agent SMANCS with lipid lymphographic agent on hepatoma: A preliminary report. Eur J Cancer Oncol 19:1053–1065, 1983

    Article  CAS  Google Scholar 

  63. Okuda K: Clinical aspects of hepatocellular carcinoma-analysis of 134 cases.In Hepatocellular Carcinoma. K Okuda, RL Peters (eds). New York, Wiley, 1976, pp 387–436

    Google Scholar 

  64. Yoshida T, Okazaki N, Yoshino M, et al: Minute hepatocellular carcinoma without appreciable change in size for seven years: A case report. Cancer 49:1491–1495, 1982

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. First Department of Medicine, Chiba University Hospital, 280, Chiba, Japan

    Kunio Okuda MD, PhD

Authors
  1. Kunio Okuda MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Okuda, K. Primary liver cancer. Digest Dis Sci 31 (Suppl 9), 133–146 (1986). https://doi.org/10.1007/BF01295995

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01295995

Keywords

Search

Navigation